33632938|t|Dexmedetomidine reverses MTX-induced neurotoxicity and inflammation in hippocampal HT22 cell lines via NCOA4-mediated ferritinophagy.
33632938|a|The incidence of chemotherapy-induced cognitive impairment (CICI) has attracted massive attention. Some studies have demonstrated the neuroprotective effects of dexmedetomidine (DEX). Here, alterations in nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy were investigated as the possible causes of DEX's neuroprotection of HT22 cells against methotrexate (MTX)-induced neurotoxicity. We used various concentrations of DEX and NCOA4-siRNA to treat MTX-induced neurotoxicity and inflammation in HT22 cells. The biomarkers of HT22 cells viability, apoptosis and inflammatory were tested. The expression of ferritinophagy markers were detected in the HT22 cells by using western blot and Immunofluorescence. We found that 10 and 50 ng/mL of DEX alleviated MTX-induced hippocampal neuronal inflammatory injuries. Meanwhile, DEX also reversed MTX-induced iron and ROS overproduction. Increasing DEX concentrations caused significant falls in the expression of ferritin heavy chain 1 (FTH1). DEX also increased vital ferritinophagy markers, NCOA4 and LC3II. NCOA4-siRNA transfection annulled the neuroprotective effects of DEX on MTX-induced inflammation in HT22 cells. Additionally, because NCOA4-siRNA disrupted ferritinophagy, DEX's inhibitory impact on MTX-induced iron and ROS overproduction in HT22 cells was also annihilated. DEX weakened MTX-provoked neurontoxicity in HT22 cells, possibly by improving NCOA4-mediated ferritinophagy. Our discoveries present further mechanisms for understanding the protective effects of DEX against MTX-induced cognitive impairment.
33632938	0	15	Dexmedetomidine	Chemical	MESH:D020927
33632938	25	28	MTX	Chemical	MESH:D008727
33632938	37	50	neurotoxicity	Disease	MESH:D020258
33632938	55	67	inflammation	Disease	MESH:D007249
33632938	83	87	HT22	CellLine	CVCL:0321
33632938	103	108	NCOA4	Gene	27057
33632938	172	192	cognitive impairment	Disease	MESH:D003072
33632938	194	198	CICI	Disease	MESH:D000084202
33632938	295	310	dexmedetomidine	Chemical	MESH:D020927
33632938	312	315	DEX	Chemical	MESH:D020927
33632938	339	369	nuclear receptor coactivator 4	Gene	27057
33632938	371	376	NCOA4	Gene	27057
33632938	446	449	DEX	Chemical	MESH:D020927
33632938	471	475	HT22	CellLine	CVCL:0321
33632938	490	502	methotrexate	Chemical	MESH:D008727
33632938	504	507	MTX	Chemical	MESH:D008727
33632938	517	530	neurotoxicity	Disease	MESH:D020258
33632938	566	569	DEX	Chemical	MESH:D020927
33632938	574	579	NCOA4	Gene	27057
33632938	595	598	MTX	Chemical	MESH:D008727
33632938	607	620	neurotoxicity	Disease	MESH:D020258
33632938	625	637	inflammation	Disease	MESH:D007249
33632938	641	645	HT22	CellLine	CVCL:0321
33632938	671	675	HT22	CellLine	CVCL:0321
33632938	707	719	inflammatory	Disease	MESH:D007249
33632938	795	799	HT22	CellLine	CVCL:0321
33632938	885	888	DEX	Chemical	MESH:D020927
33632938	900	903	MTX	Chemical	MESH:D008727
33632938	924	954	neuronal inflammatory injuries	Disease	MESH:D007249
33632938	967	970	DEX	Chemical	MESH:D020927
33632938	985	988	MTX	Chemical	MESH:D008727
33632938	997	1001	iron	Chemical	MESH:D007501
33632938	1006	1009	ROS	Chemical	-
33632938	1037	1040	DEX	Chemical	MESH:D020927
33632938	1102	1124	ferritin heavy chain 1	Gene	14319
33632938	1126	1130	FTH1	Gene	14319
33632938	1133	1136	DEX	Chemical	MESH:D020927
33632938	1182	1187	NCOA4	Gene	27057
33632938	1199	1204	NCOA4	Gene	27057
33632938	1264	1267	DEX	Chemical	MESH:D020927
33632938	1271	1274	MTX	Chemical	MESH:D008727
33632938	1283	1295	inflammation	Disease	MESH:D007249
33632938	1299	1303	HT22	CellLine	CVCL:0321
33632938	1333	1338	NCOA4	Gene	27057
33632938	1371	1374	DEX	Chemical	MESH:D020927
33632938	1398	1401	MTX	Chemical	MESH:D008727
33632938	1410	1414	iron	Chemical	MESH:D007501
33632938	1419	1422	ROS	Chemical	-
33632938	1441	1445	HT22	CellLine	CVCL:0321
33632938	1474	1477	DEX	Chemical	MESH:D020927
33632938	1487	1490	MTX	Chemical	MESH:D008727
33632938	1500	1514	neurontoxicity	Disease	
33632938	1518	1522	HT22	CellLine	CVCL:0321
33632938	1552	1557	NCOA4	Gene	27057
33632938	1670	1673	DEX	Chemical	MESH:D020927
33632938	1682	1685	MTX	Chemical	MESH:D008727
33632938	1694	1714	cognitive impairment	Disease	MESH:D003072
33632938	Negative_Correlation	MESH:D020927	MESH:D007249
33632938	Positive_Correlation	MESH:D020927	27057
33632938	Negative_Correlation	MESH:D007501	MESH:D020927
33632938	Positive_Correlation	MESH:D008727	MESH:D007249
33632938	Positive_Correlation	MESH:D007501	MESH:D008727
33632938	Negative_Correlation	MESH:D020927	MESH:D020258
33632938	Positive_Correlation	MESH:D008727	MESH:D003072
33632938	Negative_Correlation	MESH:D020927	14319
33632938	Positive_Correlation	MESH:D008727	MESH:D020258
33632938	Negative_Correlation	MESH:D008727	MESH:D020927
33632938	Negative_Correlation	MESH:D020927	MESH:D003072
33632938	Association	MESH:D007249	27057

